Kevin Raymond Merrill Smith insider trades

Open-market stock purchases and sales by Kevin Raymond Merrill Smith, CEO and President at Inogen Inc, from SEC Form 4 filings since May 29, 2020.

Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -36%.

Recent trades

DateStockTradeValue
Sep 1, 2026INGN Inogen IncBought (not open market)$8K
Mar 1, 2026INGN Inogen IncBought (not open market)$4.2K
Mar 1, 2026INGN Inogen IncBought (not open market)—
Mar 1, 2026INGN Inogen IncSold (not open market)$99.9K
Mar 1, 2026INGN Inogen IncSold (not open market)$83.6K
Mar 1, 2026INGN Inogen IncSold (not open market)$88.5K
Mar 1, 2026INGN Inogen IncBought (not open market)—
Mar 1, 2026INGN Inogen IncBought (not open market)—
Feb 27, 2026INGN Inogen IncBought (not open market)—
Dec 1, 2025INGN Inogen IncSold (not open market)$96K
Dec 1, 2025INGN Inogen IncBought (not open market)—

Companies traded

  • INGN Inogen Inc: 1 buy, last Sep 1, 2026
  • ONCS ONCOSEC MEDICAL Inc: other filings, last Jun 28, 2021

Get free alerts when Kevin Raymond Merrill Smith files a new trade →